Director, Parkinson’s Disease and Movement Disorder Center, University of South Florida
Widening the Therapeutic Window in The Management of Parkinson’s Disease
Expert neurologists discuss strategies to widen the therapeutic window of Parkinson’s disease and options available to treat dyskinesia, providing better control of Parkinson’s disease.
Widening the Therapeutic Window in the Management of Parkinson’s Disease
Unmet Needs and Future Considerations in Parkinson Disease
Robert Hauser, MD, MBA, discussed unmet needs and future consideration in Parkinson disease.
Amantadine Extended Release for the Management of Dyskinesia and OFF Episodes
Robert Hauser, MD, MBA, talks about amantadine extended release for management of dyskinesia and OFF episodes.
Treatment of OFF Time in Parkinson Disease
Robert Hauser, MD, MBA, shares his expertise in the treatment of OFF time in Parkinson disease.
Predictability of Dyskinesia and OFF Episodes in Parkinson Disease
Robert Hauser, MD, MBA, reviews the predictability of dyskinesia and OFF episodes in Parkinson disease.
Defining the Patient Experience in Parkinson Disease
Robert Hauser, MD, MBA, discusses how the patient experience is defined in Parkinson disease.
Unmet Needs and Improving Diagnosis of Dyskinesia in Parkinson Disease
The expert panel reviews unmet needs in treatment and management of dyskinesia and shares advice for physicians treating patients with Parkinson disease.
Surgical Options and Emerging Treatments for Parkinson Disease
Drs Fernando Pagan, Robert A. Hauser, and Daniel Kremens highlight existing and emerging surgical and pharmacological options for treatment of dyskinesia in Parkinson disease.
Use of Other Amantadine Formulations in Parkinson Disease
The expert neurology panel shares their clinical experience with different formulations of amantadine in management of dyskinesia in patients with Parkinson disease.
Amantadine DR/ER for Dyskinesia in Parkinson Disease: Safety Profile and Ideal Patient
The expert panel reviews the safety profile of amantadine DR/ER and who may be an ideal patient for its use in patients with Parkinson disease experiencing dyskinesia.
Studies With Amantadine-DR/ER for Treatment of Dyskinesia
The expert neurology panel discusses clinical trial data of amantadine-DR/ER in treatment of dyskinesia and OFF episodes in Parkinson disease.
Amantadine Formulations in Treatment of Dyskinesia in Parkinson Disease
Drs William G. Ondo and Rajesh Pahwa analyze the pharmacokinetics of different formulations of amantadine for treatment of dyskinesia in Parkinson disease.
Treatment of Dyskinesia in Patients with Parkinson’s Disease
Drs Rajesh Pahwa, Daniels Kremens and Fernando Pagan provide an overview of current treatment options for treatment of dyskinesia in patients with Parkinson’s Disease.
Challenges in Balancing Treatment of OFF Episodes and Dyskinesia in Parkinson Disease
The expert panel highlights challenges in treatment of OFF episodes and dyskinesia together and long-term consequences of delaying treatment for dyskinesia in patients with Parkinson disease.
Diagnosis of Dyskinesia and Impact on Quality of Life of Patients With Parkinson Disease
The expert panel shares strategies for accurate clinical diagnosis of dyskinesia in patients with Parkinson disease and discusses how dyskinesia may impact the quality of life.
Risk Factors for Dyskinesia in Patients With Parkinson Disease
The expert neurology panel examines risk factors for development of dyskinesia in patients with Parkinson disease.
Pathophysiology of Dyskinesia in Parkinson Disease
Drs William G. Ondo and Robert A. Hauser discuss the understanding of pathophysiology and clinical features of dyskinesia in patients with Parkinson disease.
Challenges With Parkinson Disease Treatments
Drs Rajesh Pahwa and Daniel E. Kremens discuss challenges with Parkinson disease treatment and management of motor fluctuations, dyskinesia and OFF episodes in patients.
Use of Parkinson Disease Treatments and Identification of OFF Episodes in Clinical Practice
The expert panel discusses advances in formulations of carbidopa/levodopa and identification of OFF and ON time in patients with Parkinson disease.
Treatment Options for Parkinson Disease
Dr William G. Ondo provides an overview of available treatments and pharmacokinetic properties of different drugs for Parkinson Disease.
Key Takeaways for Treating OFF Episodes in PD
Drs Laxman Bahroo, Rajesh Pahwa, and Robert A. Hauser share advice for neurologists treating OFF episodes in Parkinson Disease.
Emerging Therapies for the Management of PD OFF Episodes
Robert A. Hauser, MD, MBA; Laxman Bahroo, DO; and Rajesh Pahwa, MD, review emerging therapies in development for the management of OFF episodes in Parkinson Disease.
Apomorphine Infusion Devices to Manage OFF Episodes in PD
Experts in movement disorders explore the potential role of an apomorphine infusion device in the Parkinson Disease treatment landscape for patients suffering from OFF episodes.
Novel Therapeutic Administration Routes for Managing PD OFF Episodes
Robert A. Hauser, MD, MBA, and Rajesh Pahwa, MD, highlight novel administration routes for the management of OFF episodes in patients with Parkinson disease.
Assessing Effectiveness of OFF Episode Treatment in PD
Laxman Bahroo, DO, examines the effectiveness of on-demand therapies to manage OFF episodes in Parkinson disease and highlights the importance of frequent monitoring and follow-up visits.
Using On-demand Therapies for the Management of OFF Episodes in PD
Rajesh Pahwa, MD, comments on the different routes of administration of on-demand therapies and medication absorption for the management of OFF episodes in Parkinson disease.
Unmet Needs in Managing OFF Episodes in Parkinson Disease
Robert A. Hauser, MD, MBA, and Laxman Bahroo, DO, review unmet needs in managing OFF episodes for patients with Parkinson Disease.
Initiating Treatment for OFF Episodes in Parkinson Disease
Rajesh Pahwa, MD, provides insight on initiating treatment after the manifestation of OFF episodes and reviews current treatment options for Parkinson disease.
Treatment Selection for Managing OFF Episodes in Parkinson Disease
Drs Robert A. Hauser, Rajesh Pahwa, and Laxman Bahroo discuss factors to consider when approaching treatment selection for managing OFF episodes in Parkinson Disease.